KR900007941B1 - Novel microorganism for producing of glutamic acid - Google Patents

Novel microorganism for producing of glutamic acid Download PDF

Info

Publication number
KR900007941B1
KR900007941B1 KR1019880016536A KR880016536A KR900007941B1 KR 900007941 B1 KR900007941 B1 KR 900007941B1 KR 1019880016536 A KR1019880016536 A KR 1019880016536A KR 880016536 A KR880016536 A KR 880016536A KR 900007941 B1 KR900007941 B1 KR 900007941B1
Authority
KR
South Korea
Prior art keywords
glutamic acid
medium
biotin
culture
producing
Prior art date
Application number
KR1019880016536A
Other languages
Korean (ko)
Other versions
KR900009959A (en
Inventor
현형환
이윤기
정성오
심재익
오윤석
Original Assignee
제일제당 주식회사
손영희
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제일제당 주식회사, 손영희 filed Critical 제일제당 주식회사
Priority to KR1019880016536A priority Critical patent/KR900007941B1/en
Publication of KR900009959A publication Critical patent/KR900009959A/en
Application granted granted Critical
Publication of KR900007941B1 publication Critical patent/KR900007941B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Abstract

Brevibacterium lactofermentum KFCC 10654 (I) having osmotolerance and producing glutamic acid in the waste syrup or culture medium contg. 98 g/l biotin concn. without penicillin or surfactant. (I) is prepd. by treating the original strain Brevibacterium lactofermentum ATCC 13869 with UV or NTG. Prodn. of glutamic acid comprises culturing (I) in a medium contg. waste syrup, glucose, starch hydrolyte, etc., and obtaining glutamic acid from the culture broth.

Description

글루타민산을 생산하는 미생물 및 이를 이용한 글루타민산의 제조방법Microorganisms Producing Glutamic Acid and Methods for Preparing Glutamic Acid Using the Same

본 발명은 글루타민산을 생산하는 미생물 및 이를 이용한 글루타민산의 제조방법에 관한 것으로, 좀더 구체적으로는 브레비박테리움 락토퍼멘텀 ATCC 13869의 변이주로서 삼투압내성을 가짐과 동시에 배지중에 비오틴이 과잉 존재하더라도 페니실린계 항생제나 계면활성제(양이온, 음이온, 비이온계 계면활성제)를 발효 초기 또는 대수증식기 초기 내지 말기 사이에 첨가 또는 첨가하지 않아도 글루타민산을 고농도, 고수율로 생산하는 미생물에 관한 것이다.The present invention relates to a microorganism that produces glutamic acid and a method for producing glutamic acid using the same, and more specifically, as a variant of Brevibacterium lactofermentum ATCC 13869, the penicillin system has an osmotic resistance and an excessive amount of biotin in the medium. The present invention relates to a microorganism that produces glutamic acid in high concentration and high yield without adding or adding an antibiotic or a surfactant (cation, anion, nonionic surfactant) between the beginning and the end of the fermentation or the logarithmic growth stage.

종래 미생물을 이용하여 글루타민산을 생산하는 공업적 방법에서의 발효원료로는 포도당, 전분가수분해물, 폐당밀등을 사용하여 왔으나, 포도당 및 전분가수분해물이 고가라는 이유로 비오틴이 과잉(0.3-1.5μg/g)으로 존재하는 저렴한 가격의 폐당밀을 사용하므로써 발효초기 또는 대수증식기 초기 내지 말기 사이에 페니실린계 항생제나 계면활성제를 첨가하여 글루타민산을 생산하였다.In the industrial method for producing glutamic acid using microorganisms, glucose, starch hydrolyzate and waste molasses have been used as fermentation raw materials. However, excessive amounts of biotin (0.3-1.5 μg / Glutamic acid was produced by adding penicillin antibiotics or surfactants at the beginning to the end of fermentation or during the logarithmic growth phase by using low-cost waste molasses present in g).

종래 방법에서 페니실린계 항생물질등을 첨가하는 것은 이미 잘 알려진 바와같이 상기 물질이 세포벽 합성을 저해하기 때문에 세포벽의 구성물질인 펩티도글리칸 사슬(Peptidoglycan chain)의 가교결합 형성능이 불안전 하게 되므로 세포내에서 생성된 글루타민산을 세포벽을 통해 용이하게 세포외로 분비시키기 때문인 것이다.In the conventional method, the addition of penicillin-based antibiotics and the like is well known, and since the substance inhibits cell wall synthesis, the ability to form crosslinks of the peptidoglycan chain, which is a component of the cell wall, becomes unstable. This is because the glutamic acid produced in the cell is secreted easily through the cell wall.

일반적으로 글루타민산을 생산하는 브레비박테리움속이나 코리네박테리움속에 속하는 미생물들은 생장을 위해 비오틴을 요구하나 비오틴이 발효배지중에 과잉으로 존재할 경우에는 비오틴이 세포막합성을 촉진하기 때문에 글루타민산의 세포의 분비가 억제되어 글루타민산의 생산이 어려워지므로 발효배지내의 비오틴 농도를 제한할 필요가 있으나, 폐당밀을 이용할 경우에는 비오틴이 너무 과잉으로 함유되어 있어 상술한 방법에 의해서는 글루타민산을 생산할 수 없으므로 발효초기 또는 대수증식기 초기 내지 말기 사이에 페니실린계 항생제나 계면활성제를 첨가해야 생산이 가능하였다.Generally, microorganisms belonging to the genus Brevibacterium or Corynebacterium that produce glutamic acid require biotin for growth, but when biotin is present in the fermentation broth, biotin promotes cell membrane synthesis. It is necessary to limit the concentration of biotin in the fermentation broth because it is difficult to produce glutamic acid. However, when using molasses, biotin is excessively contained and glutamic acid cannot be produced by the aforementioned method. Production was possible only by the addition of penicillin antibiotics or surfactants between the beginning and end of the growth phase.

따라서 본 발명자등은 상술한 종래 방법에 의한 단점을 제거하기 위해 발효배지중 비오틴 농도에 관계없이 글루타민산의 생산에 영향을 미치지 않음과 동시에 삼투압 내성을 갖는 신규의 미생물을 획득하여 본 발명을 완성하였다.Therefore, the present inventors have completed the present invention by acquiring a novel microorganism having an osmotic resistance while not affecting the production of glutamic acid regardless of the concentration of biotin in the fermentation broth to remove the disadvantages of the conventional method described above.

본 발명 미생물이 갖는 특징중의 하나인 삼투압 내성은 호염성세균(Halophilic bacteria)이 염분이 많은 환경 즉, 세포내부와 세포외부와의 삼투의 차이가 높은 환경(배지에 염화나트륨의 농도가 높거나 또는 세포의 삼투압이 높은 환경)에서는 세포내에 특정 아미노산푸울(Amino Acid pool, 여기에서는 주로 글루타민산 또는 프롤린푸울)을 증가시켜서 세포내외의 삼투압 평형을 유지하여 생육할 수 있음에 주목하여 세포계의 Na-K펌프등 여러 가지의 생태현상을 연구, 검토한 결과, 염화나트륨 내성균주를 유도하므로써 글루타민산 푸울에 의한 삼투압평형을 유지하기 위해 세포내 글루타민산을 강력하게 생산할 수 있도록 유도된 것이다.Osmotic resistance, which is one of the characteristics of the microorganism of the present invention, is an environment in which salty salts are highly salted, that is, an environment in which the osmotic difference between the inside and the outside of the cell is high (the concentration of sodium chloride in the medium is high, or In the environment with high osmotic pressure of cells, the Na-K pump of the cell system can be increased by increasing the specific amino acid pool (Amino Acid pool, mainly glutamic acid or proline pool) in the cell to maintain the osmotic equilibrium inside and outside the cell. As a result of studying and examining various ecological phenomena, it was induced to produce intracellular glutamic acid to maintain the osmotic equilibrium caused by glutamate pool by inducing sodium chloride resistant strains.

즉, 본 발명의 미생물(KFCC 10654)은 브레비박테리움 락토퍼멘텀 ATCC 13869을 친주로하여 자외선 조사, N-메틸-N'-니트로-N-니트로소구아니딘(NTG)등의 변이유발제로 통상적인 방법으로 처리하여 대부분의 균주들이 생육할 수 없는 염화나트륨이 1.6-2.0몰농도로 함유되어 있는 염화나트륨 첨가배지(포도당 20g/l, 인산제 1 칼륨 1g/l, 인산제 2 칼륨 0.5g/l, 황산암모늄 0.5g/l, 요소 1.0g/l, 황산철 20mg/l, 황산마그네슘 0.5g/l, 황산망간 20mg/l, 티아민염산염 200μg/l, 비오틴 20μg/l, 당밀 5g/l, 염화나트륨 1.6-2.0몰, pH 7.0)에서 3-5일간 배양하고 배양액을 원심분리한후 염화나트륨의 농도가 2.0몰인 상태에서도 생육이 가능한 균체를 회수, 세정한 다음, 염화나트륨이 1.6-2.0몰농도 함유된 한천배지(염화나트륨 첨가배지조성중 한천을 20g/l 첨가한 배지)에 도말하여 콜로니를 형성시키고 형성된 콜로니를 순수분리하여 이를 다시 염화나트륨 첨가배지에서 확인을 하므로써 염화나트륨농도 1.6-2.0몰에서도 생육이 가능한 1차 변이주를 얻은 다음, 이를 다시 상술한 변이유발제로 처리한후 배지의 조성이 포도당 30g/l, 인산제 1 칼륨 1g/l, 인산제 2 칼륨 0.5g/l, 황산암모늄 0.5g/l, 요소 3.0g/l, 황산철 20μg/l, 황산마그네슘 0.5g/l, 황산망간 20mg/l, 티아민염산염 200μg/l, 당밀 5g/l, 대두박가수분해물 2g/l, 비오틴 0∼200μg/l, pH 7.0인 배지(이하 대두박 가수분해물 첨가배지라 한다)에서 비오틴의 농도에 관계없이 항상 글루타민산을 생산할 수 있는 변이주를 획득하고 1988.12.6.자로 한국종균협회에 기탁하였다(기탁번호 KFCC 10654).That is, the microorganism (KFCC 10654) of the present invention is usually used as a mutagenesis agent such as UV irradiation, N-methyl-N'-nitro-N-nitrosoguanidine (NTG), with Brevibacterium lactofermentum ATCC 13869 as a parent. Sodium chloride supplemented medium containing 1.6-2.0 molar concentrations of sodium chloride that most strains cannot grow by treatment with phosphorus (20 g / l per glucose, 1 g / l potassium phosphate, 0.5 g / l potassium phosphate, Ammonium sulfate 0.5g / l, urea 1.0g / l, iron sulfate 20mg / l, magnesium sulfate 0.5g / l, manganese sulfate 20mg / l, thiamine hydrochloride 200μg / l, biotin 20μg / l, molasses 5g / l, sodium chloride 1.6 -2.0 moles, pH 7.0) for 3-5 days, and after centrifuging the culture medium, the cells that can be grown even when the concentration of sodium chloride is 2.0 moles are recovered and washed, and agar medium containing 1.6-2.0 molar concentrations of sodium chloride is used. To form colonies by smearing in (Medium added with 20 g / l of agar in the medium of sodium chloride) Pure colony of the formed colony was confirmed again in the sodium chloride addition medium to obtain a primary mutant strain that can be grown even at a sodium chloride concentration of 1.6-2.0 mol, and then treated with the above-mentioned mutagenesis agent, the composition of the medium is 30 g / l , 1 g / l potassium phosphate, 0.5 g / l potassium phosphate, 0.5 g / l ammonium sulfate, 3.0 g / l urea, 20 μg / l iron sulfate, 0.5 g / l magnesium sulfate, 20 mg / l manganese sulfate, Glutamic acid will always be produced regardless of the concentration of biotin in a medium with 200 μg / l thiamine hydrochloride, 5 g / l molasses, 2 g / l soybean hydrolyzate, 0-200 μg / l biotin, pH 7.0 Mutant strains were obtained and deposited with the Korean spawn association as of January 1, 1988 (Accession No. KFCC 10654).

본 발명 미생물의 특성은 다음의 표에 기재된 바와 같다.The characteristics of the microorganism of the present invention are as described in the following table.

[표 1] 염화나트륨에 대한 내성비교[Table 1] Comparison of Resistance to Sodium Chloride

Figure kpo00001
Figure kpo00001

<주> 사용배지 ; 한천배지<Note> Medium used; Agar Badge

+ ; 생육, - ; 생육치못함+; Growth,-; Inability to grow

[표 2] 비오틴농도에 따른 글루타민산 생산비교[Table 2] Comparison of glutamic acid production according to biotin concentration

Figure kpo00002
Figure kpo00002

Figure kpo00003
Figure kpo00003

<주> 배지는 대두박가스분해물 첨가배지를 사용하여 글루타민산의 생산을 확인하였으며 종배양배지는 염화나트륨첨가 배지의 조성중 염화나트륨을 제거시킨 배지를 사용, 균주를 접종배양하였으며 OD562에서 약 4.0정도가 될때 원심분리하여 균체를 회수한 후 생리식염수로 2∼3회 세정하여 배지중 잔존비오틴을 완전히 제거한후 종균으로 사용하였다.<Note> the medium was confirmed in the production of glutamic acid by using the soybean meal gas decomposition product added medium seed culture medium is used a medium which removes the joseongjung sodium chloride in sodium chloride added to the medium, were inoculated with cultured strain centrifugal when approximately 4.0 OD 562 After separation, the cells were recovered and washed two to three times with physiological saline to completely remove the remaining biotin in the medium, and used as a seed.

글루타민산의 생산확인은 대두박가수분해물 첨가배지를 250ml용량의 삼각플라스크에 각 40ml씩 분주하여 살균, 냉각후 사용하였으며 rpm 220, 30℃에서 72시간 진탕배양하였다.The production of glutamic acid was determined by dispensing 40 ml of soybean meal hydrolysate medium into a 250 ml Erlenmeyer flask, sterilized and cooled, and incubated at rpm 220 and 30 ° C for 72 hours.

다음의 실시예에서 본 발명을 좀더 구체적으로 설명한다.The present invention is explained in more detail in the following examples.

실시예 1Example 1

사용균주 ; 본 발명 미생물(KFCC 10654), ATCC 13869Used strain; Microorganism of the Invention (KFCC 10654), ATCC 13869

종배지 ; 폐당밀 0.5%, 포도당 2.0%, MgSO40.5g/l, 요소 0.1%, FeSO420mg/l, K2HPO40.5g/l, KH2PO41g/l, (NH4)2SO40.5%, 티아민염산염 200μg/l, 비오틴 20μg/1, pH 7.0.Species medium; Waste molasses 0.5%, glucose 2.0%, MgSO 4 0.5g / l, urea 0.1%, FeSO 4 20mg / l, K 2 HPO 4 0.5g / l, KH 2 PO 4 1g / l, (NH 4 ) 2 SO 4 0.5%, thiamine hydrochloride 200 μg / l, biotin 20 μg / 1, pH 7.0.

발효배지; 폐당밀(전화당으로) 4%, KH2PO41g/l, K2HPO40.5g/l, (NH4)2SO40.5g/l, FeSO420mg/l, MgSO40.5g/l, MnSO420mg/l, 요소 30g/l, 티아민염산염 200μg/l, 대두박추출물 2g/l, pH 7.0.Fermentation medium; Waste molasses (as invert sugar) 4%, KH 2 PO 4 1 g / l, K 2 HPO 4 0.5 g / l, (NH 4 ) 2 SO 4 0.5 g / l, FeSO 4 20 mg / l, MgSO 4 0.5 g / l, MnSO 4 20 mg / l, urea 30 g / l, thiamine hydrochloride 200 μg / l, soybean extract 2 g / l, pH 7.0.

종배양 ; 상기 종배지 40ml씩 250ml용량의 배양용 삼각플라스크에 분주하고 살균, 냉각후 상기 균주를 식균하여 약 16-20시간(30℃, 180rpm)진탕배양하여 종균으로 사용하였다.Species culture; 40 ml of each seed medium was dispensed into a 250 ml culture Erlenmeyer flask, and after sterilization and cooling, the strain was inoculated and cultured for about 16-20 hours (30 ° C., 180 rpm) to be used as a spawn seed.

발효방법 ; 발효배지를 250ml용량의 삼각플라스크에 40ml씩 분주하여 살균(121℃, 10분), 냉각한후 종균을 1ml씩 식균하고 약 72시간(32℃, 220rpm)진탕배양하였다. 배양완료액중 글루타민산의 축적량은 표 3의 기재와 같다.Fermentation method; The fermentation broth was dispensed by dispensing 40 ml each into a 250 ml Erlenmeyer flask, sterilized (121 ° C., 10 minutes), cooled, and seeded with 1 ml each and cultured for about 72 hours (32 ° C., 220 rpm). The accumulation amount of glutamic acid in the culture completed solution is shown in Table 3.

[표 3]TABLE 3

Figure kpo00004
Figure kpo00004

본 실시예에서 사용한 당밀은 필리핀산 사탕수수당밀로써 비오틴의 함량은 당밀 1g당 1.4μg이었고 발효 배지중의 비오틴농도는 98μ/l이었다.The molasses used in this example was a sugar cane molasses from the Philippines, and the biotin content was 1.4 μg per 1 g of molasses, and the biotin concentration in the fermentation medium was 98 μL.

본 실시예의 결과, 본 발명의 미생물은 발효배지중 비오틴의 농도가 과잉이라 할지라도 페니실린계 항생제 또는 계면활성제를 첨가하지 않아도 고농도의 글루타민산을 생산할 수 있음이 확인되었다.As a result of this example, it was confirmed that the microorganism of the present invention can produce a high concentration of glutamic acid even without adding penicillin antibiotic or surfactant even if the concentration of biotin in the fermentation broth is excessive.

실시예 2Example 2

사용균주 ; 실시예 1과 동일Used strain; Same as Example 1

1차종배지 ; 폐당밀 0.5%, 포도당 2.0%, MgSO40.5g/l, 요소 0.1%, FeSO420mg/l, MnSO420mg/l, K2HPO40.5g/l, KH2PO41g/l, (NH4)2SO40.5%, 티아민염산염 200μg/l, 비오틴 20μg/1, pH 7.0.Primary species medium; Waste molasses 0.5%, glucose 2.0%, MgSO 4 0.5g / l, urea 0.1%, FeSO 4 20mg / l, MnSO 4 20mg / l, K 2 HPO 4 0.5g / l, KH 2 PO 4 1g / l, ( NH 4 ) 2 SO 4 0.5%, thiamine hydrochloride 200 μg / l, biotin 20 μg / 1, pH 7.0.

2차종배지 ; 폐당밀(전화당으로) 2.0%, 글루코오스 1%, 콘스팁리커 3%, MgSO40.5g/l, 요소 0.2%, KH2PO41g/l, K2HPO40.5g/l, FeSO410mg/l, MnSO410mg/l, MnSO420mg/l, (NH4)2SO40.3%, 티아민염산염 200μg/l, 비오틴 100μg/l, 소포제 약간, pH 7.0.Secondary species medium; Lung molasses (as invert sugar) 2.0%, glucose 1%, cornsipsticker 3%, MgSO 4 0.5 g / l, urea 0.2%, KH 2 PO 4 1 g / l, K 2 HPO 4 0.5 g / l, FeSO 4 10 mg / l, MnSO 4 10 mg / l, MnSO 4 20 mg / l, (NH 4 ) 2 SO 4 0.3%, thiamine hydrochloride 200 μg / l, biotin 100 μg / l, antifoam slightly, pH 7.0.

발효배지 ; 폐당밀(전화당으로) 8%, NH4H2PO40.15%, FeSO410mg/l, MnSO410mg/l, 콘스팁리커 3%, (NH4)2SO40.3%, 티아민염산염 200μg/l, 소포제 약간, pH 7.0.Fermentation medium; Waste molasses (as invert sugar) 8%, NH 4 H 2 PO 4 0.15%, FeSO 4 10 mg / l, MnSO 4 10 mg / l, corn steep liquor 3%, (NH 4 ) 2 SO 4 0.3%, thiamine hydrochloride 200 μg / l, antifoam slightly, pH 7.0.

1차종배양 ; 1차종배지를 40ml씩 삼각플라스크에 넣고 살균후 균주를 접종하여 180rpm, 30℃에서 20-24시간 진탕배양하였다.Primary species culture; The primary seed medium was put in a 40ml Erlenmeyer flask and inoculated with the strain after sterilization and cultured at 180 rpm and 30 ° C for 20-24 hours.

2차종배양 ; 2차종배지를 2.6리터 용량의 시험용발효조에 각 1.2리터씩 분주하고 121℃에서 10분간 살균, 냉각후 1차종배양에서 얻은 배양완료액을 5ml씩 접종한후 공기를 매분당 0.5-1.0리터 공급하면서 900rpm, 30℃에서 12-15시간 진탕배양하였다.Secondary species culture; After dispensing 1.2 liters into a 2.6 liter test fermentation tank, sterilized for 10 minutes at 121 ° C, inoculating 5 ml of the culture solution obtained in the primary culture, and supplying 0.5-1.0 liters of air per minute. Shake culture was carried out at 900rpm, 30 ℃ for 12-15 hours.

발효방법 ; 상기 발효배지를 5리터 용량의 시험발효조에 1.8리터씩 분주하고 121℃에서 1분간 살균, 냉각하여 2차종배양액을 약 150ml씩 접종한후, 공기를 매분당 1-2.5리터씩 공급하면서 900rpm, 30-37℃에서 진탕배양하였다.Fermentation method; 1.8 liters of the fermentation broth was dispensed in a 5-liter test fermenter, sterilized and cooled at 121 ° C. for 1 minute, inoculated with about 150 ml of the secondary culture medium, and then supplied with 1-2.5 liters of air at 900 rpm for 30 minutes. Shake culture at -37 ℃.

상기 조건으로 배양하여 대수증식기 초기 내지 말기[OD5620.15-0.4(OD562×100)]사이에 페니실린을 0.3-1.2μ/ml 첨가하고 배양하며 배양중 배양액의 pH는 암모니아수로 pH 7.8가 되도록 계속 조절하였다.Incubate under the above conditions and add 0.3-1.2μ / ml of penicillin between the early and the late stage of logarithmic growth [OD 562 0.15-0.4 (OD 562 × 100)], and keep the culture medium at pH 7.8 with ammonia water. Adjusted.

배양중 잔존당의 농도가 0.5-1.5%가 되면 살균된 폐당밀 또는 폐당밀과 원당을 일정비율로 혼합한 당을 수시로 공급하였다.When the concentration of residual sugar in the culture was 0.5-1.5%, sterile lung molasses or a mixture of waste molasses and raw sugars was supplied at a constant rate.

추가한 당밀 또는 혼합당과 초기의 발효배지에 첨가된 당의 합계가 발효액량 대비 19%가 될때까지 계속 배양하였다. 배양완료후 글루타민산의 농도는 ATCC 13869가 103.7g/l, KFCC 10654이 137.8g/l이었다.Culture was continued until the sum of added molasses or mixed sugar and sugar added to the initial fermentation broth was 19% of the fermentation broth. After completion of the culture, the concentration of glutamic acid was 103.7 g / l for ATCC 13869 and 137.8 g / l for KFCC 10654.

실시예 3Example 3

사용균주, 1차 및 2차종배지, 발효배지, 1차 및 2차종배양은 실시예 2와 동일하게 행하였다.Strains used, primary and secondary seed media, fermentation broth, primary and secondary seed cultures were carried out in the same manner as in Example 2.

발효방법 ; OD가 0.1-0.3(OD562×100)정도가 될때 비이온계 계면활성제인 트윈 40을 발효액 대비 50-100μg/ml가 되도록 첨가하여 배양한 것을 제외하고는 실시예 2와 동일하게 행한 결과, 발효완료액의 글루타민산의 농도는 ATCC 13869가 106.8g/l, KFCC 10654가 138.3g/l이었다.Fermentation method; When OD was about 0.1-0.3 (OD 562 × 100), fermentation was carried out in the same manner as in Example 2 except that Tween 40, a nonionic surfactant, was added to 50-100 μg / ml relative to the fermentation broth. The concentration of glutamic acid in the finished solution was 106.8 g / l for ATCC 13869 and 138.3 g / l for KFCC 10654.

Claims (2)

삼투압내성을 가짐과 동시에 폐당 및 발효배지내 비오틴 농도 98μg/l존재하에서, 페니실린 항생제 또는 계면활성제를 첨가하지 않아도 글루타민산을 생산함을 특징으로 하는 브레비박테리움 락토퍼멘텀 KFCC 10654.Brevibacterium lactofermentum KFCC 10654, characterized by producing glutamic acid with osmotic resistance and in the presence of 98 μg / l biotin concentration in waste sugar and fermentation broth without the addition of penicillin antibiotics or surfactants. 브레비박테리움 락토퍼멘텀 KFCC 10654를 폐당밀, 포도당, 전분가수분해물 및 원당등이 포함된 배지중에서 배양하여 배양물로부터 글루타민산을 채취하는 것을 특징으로 하는 미생물을 이용한 글루타민산의 제조방법.A method for producing glutamic acid using microorganisms, comprising culturing Brevibacterium lactofermentum KFCC 10654 in a medium containing waste molasses, glucose, starch hydrolysate, and raw sugar.
KR1019880016536A 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid KR900007941B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019880016536A KR900007941B1 (en) 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880016536A KR900007941B1 (en) 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid

Publications (2)

Publication Number Publication Date
KR900009959A KR900009959A (en) 1990-07-06
KR900007941B1 true KR900007941B1 (en) 1990-10-23

Family

ID=19280072

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016536A KR900007941B1 (en) 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid

Country Status (1)

Country Link
KR (1) KR900007941B1 (en)

Also Published As

Publication number Publication date
KR900009959A (en) 1990-07-06

Similar Documents

Publication Publication Date Title
KR100402320B1 (en) A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5&#39;-xanthylic acid in higher yield and a producing method of 5&#39;-xanthylic acid by using the same
KR900007941B1 (en) Novel microorganism for producing of glutamic acid
KR900007942B1 (en) Novel microorganism for producing of glutamin acid
KR100220018B1 (en) Novel corynebacterium glutamicum ch45 which produce l-leucine
KR100344018B1 (en) 5&#39;-Xanthylic acid producing microorganism
KR100344016B1 (en) 5&#39;-Xanthylic acid producing microorganism
KR900007943B1 (en) Novel microorganism for producing of glutamic acid
KR20010089980A (en) 5&#39;-Xanthylic acid producing microorganism
US3939042A (en) Process for the production of L-glutamic acid
KR100264740B1 (en) A microorganism producing glutamic acid and a producing method of the glutamic acid using the same
KR900007948B1 (en) Novel microorganism for producing of glutamic acid
KR100273950B1 (en) Corynebacterium glutamicum CJ31-0210 producing L-lysine and method for producing L-lysine using the same
US7456010B2 (en) Microorganism producing 5′-xanthylic acid
KR900007945B1 (en) Novel microorganism for producing of glutamic acid
KR900007946B1 (en) Novel microorganism for producing of glutamic acid
KR100402322B1 (en) A microorganism Corynebacterium ammoniagenes CJXP002 being capable of producing 5&#39;-xanthylic acid in higher yield and a producing method of 5&#39;-xanthylic acid by using the same
KR900007947B1 (en) Novel microorganism for producing of glutamic acid
KR910007856B1 (en) Method for producing l-glutamic acid
KR900007938B1 (en) Novel microorganism for producing of glutamic acid
KR900007944B1 (en) Novel microorganism for producing of glutamic acid
KR100317902B1 (en) A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism
KR900007940B1 (en) Novel microorganism for producing of glutamic acid
KR100264741B1 (en) A microorganism producing glutamic acid and a producing method of the glutamic acid using the same
KR100292298B1 (en) Microorganism producing glutamic acid and process for preparation glutamic acid using the same
KR100317901B1 (en) A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010917

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee